Prosecution Insights
Last updated: October 04, 2026

Ketoneaid Inc.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

8 pending office actions • 3 art units • 3 examiners • 0 of 8 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Ketoneaid Inc. currently has 6 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 6 actions are being handled by 3 distinct examiners, which indicates a concentration of matters among a small group of personnel. The portfolio is also distributed across 3 distinct art units, suggesting that the company's Biotechnology & Pharmaceuticals applications are evaluated by several specialized technical groups within the patent office.

The busiest examiner for the portfolio is Stulii, Vera, who is responsible for 3 of the pending office actions. Since Stulii, Vera manages 3 out of the 6 total actions, this examiner's specific feedback and requirements will be a dominant factor in the company's current prosecution efforts. The 3 distinct art units involved mean that the 6 pending office actions are subject to the specific guidelines of three different examination groups, requiring a tailored approach for each case.

Practitioners managing these 6 pending office actions must prioritize the relationship with Stulii, Vera, given their oversight of 3 cases. The presence of 3 distinct examiners and 3 distinct art units for 6 actions shows that the portfolio is distributed across multiple procedural silos. This distribution requires a strategy that addresses the specific technical nuances of each Biotechnology & Pharmaceuticals art unit while managing the significant influence of the busiest examiner on the overall portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

8
Total Pending OAs
5
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (25%)
4
Medium (50%)
2
Easy (25%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (25%)
Double-patenting only2 (25%)
Double-patenting + other2 (25%)
Multi-statute (no §101)2 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
75% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FRONDA, CHRISTIAN L 4 82.4% +14.2%
STULII, VERA 3 32.8% +24.8%
ZILBERING, ASSAF 1 35.2% +27.8%

Quick Wins (4)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18678629 EXOGENOUS KETONE BLEND COMPOSITIONS FOR DELIVERY OF KETONE BODIES FRONDA, CHRISTIAN L 4d overdue
19676472 FOODSTUFF CONTAINING R 1,3 BUTANEDIOL FOR KETOSIS, ENERGY, AND MENTAL CLARITY FRONDA, CHRISTIAN L —
19578476 R-BUTYLENE GLYCOL TOPICAL COMPOSITIONS FOR ANTI-AGING, SKIN PROTECTION AND HAIR TREATMENT FRONDA, CHRISTIAN L —
19544207 COMPOSITION OF D B-HYDROXYBUTYRATE SALTS FRONDA, CHRISTIAN L —

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19534368 BEVERAGE CONTAINING R 1,3 BUTANEDIOL STULII, VERA —
19174611 KETONE BEVERAGE CONTAINING CAFFEINE AND (R)-1,3-BUTANEDIOL AND/OR (R)-BETA-HYDROXYBUTYRIC ACID AND SALTS ZILBERING, ASSAF —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18678629 EXOGENOUS KETONE BLEND COMPOSITIONS FOR DELIVERY OF KETONE BODIES FRONDA, CHRISTIAN L 4d overdue
19676472 FOODSTUFF CONTAINING R 1,3 BUTANEDIOL FOR KETOSIS, ENERGY, AND MENTAL CLARITY FRONDA, CHRISTIAN L —
19578476 R-BUTYLENE GLYCOL TOPICAL COMPOSITIONS FOR ANTI-AGING, SKIN PROTECTION AND HAIR TREATMENT FRONDA, CHRISTIAN L —
19544207 COMPOSITION OF D B-HYDROXYBUTYRATE SALTS FRONDA, CHRISTIAN L —
19534368 BEVERAGE CONTAINING R 1,3 BUTANEDIOL STULII, VERA —
19174611 KETONE BEVERAGE CONTAINING CAFFEINE AND (R)-1,3-BUTANEDIOL AND/OR (R)-BETA-HYDROXYBUTYRIC ACID AND SALTS ZILBERING, ASSAF —
18894874 BEVERAGE CONTAINING R-1,3-BUTANEDIOL AND D-BETA-HYDROXYBUTYRIC ACID STULII, VERA —
18894890 BEVERAGE CONTAINING R-1,3-BUTANEDIOL OR R-1,3-BUTANEDIOL AND ETHANOL STULII, VERA —

Top Art Units

Art UnitApps
1652 4
1791 1
1792 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19676472 FOODSTUFF CONTAINING R 1,3 BUTANEDIOL FOR KETOSIS, ENERGY, AND MENTAL CLARITY FRONDA, CHRISTIAN L 1652 §103DP Non-Final OA — Pending May 13, 2026
19578476 R-BUTYLENE GLYCOL TOPICAL COMPOSITIONS FOR ANTI-AGING, SKIN PROTECTION AND HAIR TREATMENT FRONDA, CHRISTIAN L 1652 §103DP Non-Final OA — Pending Mar 25, 2026
19544207 COMPOSITION OF D B-HYDROXYBUTYRATE SALTS FRONDA, CHRISTIAN L 1652 DP Final Rejection — Pending Feb 19, 2026
19534368 BEVERAGE CONTAINING R 1,3 BUTANEDIOL STULII, VERA 1791 §102§103 Final Rejection — Pending Feb 09, 2026
19174611 KETONE BEVERAGE CONTAINING CAFFEINE AND (R)-1,3-BUTANEDIOL AND/OR (R)-BETA-HYDROXYBUTYRIC ACID AND SALTS ZILBERING, ASSAF 1792 §103§112 Non-Final OA — Pending Apr 09, 2025
18894874 BEVERAGE CONTAINING R-1,3-BUTANEDIOL AND D-BETA-HYDROXYBUTYRIC ACID STULII, VERA — §103Other Non-Final OA — Pending Sep 24, 2024
18894890 BEVERAGE CONTAINING R-1,3-BUTANEDIOL OR R-1,3-BUTANEDIOL AND ETHANOL STULII, VERA — §103Other Non-Final OA — Pending Sep 24, 2024
18678629 EXOGENOUS KETONE BLEND COMPOSITIONS FOR DELIVERY OF KETONE BODIES FRONDA, CHRISTIAN L 1652 DP Final Rejection 4d overdue Pending May 30, 2024

Managing Ketoneaid Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month